| Dr Asad Shafiq, MD, | |
|
1000 E Mountain Dr, Wilkes Barre, PA 18711-0027 | |
| (570) 808-4047 | |
| (570) 808-4051 |
| Full Name | Dr Asad Shafiq |
|---|---|
| Gender | Male |
| Speciality | Nephrology |
| Experience | 16 Years |
| Location | 1000 E Mountain Dr, Wilkes Barre, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1245662428 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RN0300X | Internal Medicine - Nephrology | 28099 (West Virginia) | Secondary |
| 207RN0300X | Internal Medicine - Nephrology | MD468090 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Geisinger Wyoming Valley Medical Center | Wilkes barre, PA | Hospital |
| Geisinger-community Medical Center | Scranton, PA | Hospital |
| Wilkes-barre General Hospital | Wilkes-barre, PA | Hospital |
| Geisinger Medical Center | Danville, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Geisinger Clinic | 5395657001 | 2866 |
News Archive
A study led by researchers at the Babraham Institute in collaboration with the Wellcome Sanger Institute has uncovered how variations in a non-protein coding 'dark matter' region of the genome could make patients susceptible to complex autoimmune and allergic diseases such as inflammatory bowel disease.
Adverse cardiac events are rare one year after patients are admitted to the emergency room with low-to-moderate risk chest pain and are discharged due to a negative cardiac computed tomography angiogram (CTA), according to a study in the October issue of the American Journal of Roentgenology. Cardiac CTA is a noninvasive heart-imaging test that determines whether fatty deposits or calcium deposits have built up in the coronary arteries that supply blood to the heart muscle.
Immune Pharmaceuticals Inc. announces today that it has initiated the screening of patients for a Phase II proof of concept clinical trial exploring the safety and efficacy of bertilimumab in the treatment of ulcerative colitis (UC).
Vanguard Health Systems, Inc. ("Vanguard") announced the closing today of the private placement offering of $950.0 million aggregate principal amount of 8% Senior Notes due 2018 (the "Notes") co-issued by Vanguard's subsidiaries, Vanguard Health Holding Company II, LLC ("VHS Holdco II") and Vanguard Holding Company II, Inc. ("VHS Holdco II Inc." and, together with VHS Holdco II, the "Issuers").
Summer officially arrives at 6:07 a.m. on Thursday. And typically, the first two months of summer coincide with the height of poison ivy season.
› Verified 6 days ago
| Entity Name | Geisinger Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366493868 PECOS PAC ID: 5395657001 Enrollment ID: O20040130000518 |
News Archive
A study led by researchers at the Babraham Institute in collaboration with the Wellcome Sanger Institute has uncovered how variations in a non-protein coding 'dark matter' region of the genome could make patients susceptible to complex autoimmune and allergic diseases such as inflammatory bowel disease.
Adverse cardiac events are rare one year after patients are admitted to the emergency room with low-to-moderate risk chest pain and are discharged due to a negative cardiac computed tomography angiogram (CTA), according to a study in the October issue of the American Journal of Roentgenology. Cardiac CTA is a noninvasive heart-imaging test that determines whether fatty deposits or calcium deposits have built up in the coronary arteries that supply blood to the heart muscle.
Immune Pharmaceuticals Inc. announces today that it has initiated the screening of patients for a Phase II proof of concept clinical trial exploring the safety and efficacy of bertilimumab in the treatment of ulcerative colitis (UC).
Vanguard Health Systems, Inc. ("Vanguard") announced the closing today of the private placement offering of $950.0 million aggregate principal amount of 8% Senior Notes due 2018 (the "Notes") co-issued by Vanguard's subsidiaries, Vanguard Health Holding Company II, LLC ("VHS Holdco II") and Vanguard Holding Company II, Inc. ("VHS Holdco II Inc." and, together with VHS Holdco II, the "Issuers").
Summer officially arrives at 6:07 a.m. on Thursday. And typically, the first two months of summer coincide with the height of poison ivy season.
› Verified 6 days ago
| Entity Name | Guthrie Medical Group Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962451153 PECOS PAC ID: 6002728656 Enrollment ID: O20040301000571 |
News Archive
A study led by researchers at the Babraham Institute in collaboration with the Wellcome Sanger Institute has uncovered how variations in a non-protein coding 'dark matter' region of the genome could make patients susceptible to complex autoimmune and allergic diseases such as inflammatory bowel disease.
Adverse cardiac events are rare one year after patients are admitted to the emergency room with low-to-moderate risk chest pain and are discharged due to a negative cardiac computed tomography angiogram (CTA), according to a study in the October issue of the American Journal of Roentgenology. Cardiac CTA is a noninvasive heart-imaging test that determines whether fatty deposits or calcium deposits have built up in the coronary arteries that supply blood to the heart muscle.
Immune Pharmaceuticals Inc. announces today that it has initiated the screening of patients for a Phase II proof of concept clinical trial exploring the safety and efficacy of bertilimumab in the treatment of ulcerative colitis (UC).
Vanguard Health Systems, Inc. ("Vanguard") announced the closing today of the private placement offering of $950.0 million aggregate principal amount of 8% Senior Notes due 2018 (the "Notes") co-issued by Vanguard's subsidiaries, Vanguard Health Holding Company II, LLC ("VHS Holdco II") and Vanguard Holding Company II, Inc. ("VHS Holdco II Inc." and, together with VHS Holdco II, the "Issuers").
Summer officially arrives at 6:07 a.m. on Thursday. And typically, the first two months of summer coincide with the height of poison ivy season.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Asad Shafiq, MD, 100 N Academy Ave, Danville, PA 17822-4903 Ph: (570) 271-6144 | Dr Asad Shafiq, MD, 1000 E Mountain Dr, Wilkes Barre, PA 18711-0027 Ph: (570) 808-4047 |
News Archive
A study led by researchers at the Babraham Institute in collaboration with the Wellcome Sanger Institute has uncovered how variations in a non-protein coding 'dark matter' region of the genome could make patients susceptible to complex autoimmune and allergic diseases such as inflammatory bowel disease.
Adverse cardiac events are rare one year after patients are admitted to the emergency room with low-to-moderate risk chest pain and are discharged due to a negative cardiac computed tomography angiogram (CTA), according to a study in the October issue of the American Journal of Roentgenology. Cardiac CTA is a noninvasive heart-imaging test that determines whether fatty deposits or calcium deposits have built up in the coronary arteries that supply blood to the heart muscle.
Immune Pharmaceuticals Inc. announces today that it has initiated the screening of patients for a Phase II proof of concept clinical trial exploring the safety and efficacy of bertilimumab in the treatment of ulcerative colitis (UC).
Vanguard Health Systems, Inc. ("Vanguard") announced the closing today of the private placement offering of $950.0 million aggregate principal amount of 8% Senior Notes due 2018 (the "Notes") co-issued by Vanguard's subsidiaries, Vanguard Health Holding Company II, LLC ("VHS Holdco II") and Vanguard Holding Company II, Inc. ("VHS Holdco II Inc." and, together with VHS Holdco II, the "Issuers").
Summer officially arrives at 6:07 a.m. on Thursday. And typically, the first two months of summer coincide with the height of poison ivy season.
› Verified 6 days ago
Dr. Paul Anthony Arkless, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1000 E Mountain Dr, Pulmonary Department, Wilkes Barre, PA 18711 Phone: 570-808-5770 | |
Dr. Lida Eatedali, MD Nephrology Medicare: Not Enrolled in Medicare Practice Location: 1111 East End Blvd, Vamc., Wilkes Barre, PA 18711 Phone: 570-824-3521 | |
Dr. Sanjaykumar Doshi, MD Nephrology Medicare: Not Enrolled in Medicare Practice Location: Va Medical Center, 1111 East End Blvd, Wilkes Barre, PA 18702 Phone: 570-824-3521 | |
Dr. Smita S. Nikam, M.D. Nephrology Medicare: Medicare Enrolled Practice Location: 1000 E Mountain Blvd, Wilkes Barre, PA 18711 Phone: 570-820-6114 Fax: 570-826-7698 | |
Carol L Myers, DO Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1000 E Mountain Blvd, Wilkes Barre, PA 18711 Phone: 570-808-6444 Fax: 570-808-5040 | |
Patrick Michael Aquilina, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 545 N River St Ste 240, Wilkes Barre, PA 18702 Phone: 570-819-2825 Fax: 570-819-1445 | |
Dr. Richard Abbas Alley, MD Nephrology Medicare: Not Enrolled in Medicare Practice Location: 166 Hanover St, 203, Wilkes Barre, PA 18702 Phone: 570-825-8780 Fax: 570-825-8785 |